TrumpRx’s slow start | STAT

Mary Talley Bowden, a physician who recently won a lengthy legal battle with the Texas Medical Board over her license to prescribe ivermectin, has now been granted permission to sell the medication. This news comes as a relief to Bowden, who faced significant challenges in obtaining the necessary approvals to distribute ivermectin to patients in need.

The contentious nature of Bowden’s case highlights the ongoing debate surrounding the use of ivermectin as a treatment for various medical conditions, including COVID-19. Despite conflicting opinions among medical professionals and regulatory bodies, Bowden remained steadfast in her belief that ivermectin could provide relief for her patients.

In other health news, the White House is reportedly preparing to nominate a new leader for the Centers for Disease Control and Prevention (CDC). However, senators responsible for confirming the nominee have been left in the dark about the administration’s plans. This lack of communication has raised concerns about the transparency of the selection process and the potential impact on the CDC’s ability to effectively respond to public health challenges.

As developments unfold in the healthcare sector, it is essential for policymakers, healthcare providers, and the public to stay informed and engaged. Stay tuned for more updates on these and other important healthcare issues.

For more information and news tips, please contact [email protected] or John_Wilkerson.07 on Signal.